1. Lee JY, Kim M. Current issues in migraine genetics. J Clin Neurol. 2005. 1:8–13.
Article
2. Welch KM, Ramadan NM. Mitochondria, magnesium and migraine. J Neurol Sci. 1995. 134:9–14.
Article
3. Klopstock T, May A, Seibel P, Papagiannuli E, Diener HC, Reichmann H. Mitochondrial DNA in migraine with aura. Neurology. 1996. 46:1735–1738.
Article
4. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia. 2006. 26:361–372.
5. Haan J, Terwindt GM, Maassen JA, Hart LM, Frants RR, Ferrari MD. Search for mitochondrial DNA mutations in migraine subgroups. Cephalalgia. 1999. 19:20–22.
Article
6. Shimomura T KA, Marukawa H, Takahashi K. Mutation in platelet mitochondrial gene in patients with migraine. Cephalalgia. 1995. 15:10.
7. Russell MB, Diamant M, Norby S. Genetic heterogeneity of migraine with and without aura in Danes cannot be explained by mutation in mtDNA nucleotide pair 11084. Acta Neurol Scand. 1997. 96:171–173.
Article
8. Matsumoto H, Miyazaki T, Suzuki K. Characteristics of japanese, Korean, and Chinese populations based on the genetic markers of human immunoglobulins. Z Morphol Anthropol. 1995. 81:23–32.
Article
9. Min PG. A comparison of the Korean minorities in China and Japan. Int Migr Rev. 1992. 26:4–21.
Article
10. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004. 24:Suppl 1. 9–160.
11. Ingman M, Kaessmann H, Pääbo S, Gyllensten U. Mitochondrial genome variation and the origin of modern humans. Nature. 2000. 408:708–713.
Article
12. Mishmar D, Ruiz-Pesini E, Golik P, Macaulay V, Clark A, Hosseini S, et al. Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci USA. 2003. 100:171–176.
Article
13. Sakuta R, Goto Y, Nonaka I, Horai S. An A-to-G transition at nucleotide pair 11084 in the ND4 gene may be an mtDNA polymorphism. Am J Hum Genet. 1993. 53:964–965.
14. Takeshima T, Fukuhara Y, Adachi Y, Ishizaki K, Kusumi M, Kowa H, et al. Leukocyte mitochondrial DNA A to G polymorphism at 11084 is not a risk factor for Japanese migraineurs. Cephalalgia. 2001. 21:987–989.
Article
15. Lehmann-Horn F. Disease-causing mutations or functional polymorphisms? Acta Myol. 2004. 23:85–89.
16. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995. 311:541–544.
Article
17. Ziegler DK, Hur YM, Bouchard TJ Jr, Hassanein RS, Barter R. Migraine in twins raised together and apart. Headache. 1998. 38:417–422.
Article
18. Joutel A, Bousser MG, Biousse V, Labauge P, Chabriat H, Nibbio A, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993. 5:40–45.
Article
19. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996. 87:543–552.
Article
20. Tournier-Lasserve E. Sandler M, Ferrari M, Harnett S, editors. Genetics of familial hemiplegic migraine. Migraine: Pharmacology and Genetics. 1996. 1st edn. London: Chapman & Hall;282–290.
21. Dichgans M, Forderreuther S, Deiterich M, Pfaffenrath V, Gasser T. The D2 receptor NcoI allele: absence of allelic association with migraine with aura. Neurology. 1998. 51:928.
22. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology. 1997. 49:201–206.
Article
23. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med. 1998. 4:14–21.
Article
24. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007. 13:39–44.
Article
25. Montagna P. Magnetic resonance spectroscopy in migraine. Cephalalgia. 1995. 15:323–327.
Article